Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-14

Clinical Trial Update: Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating Saccharomyces cerevisiae for symptoms of irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces cerevisiae (Saccharomyces cerevisiae)

Snippet

Sponsor: Lesaffre International | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED